ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia

While the role of ASLX1 in haematopoiesis and leukaemia has been heavily studied, the role of ASLX2 is unclear. Here the authors show that ASLX2 is required for normal haematopoietic stem cell self-renewal whereas Asxl2 loss promotes leukemogenesis, thus explaining the frequently observed mutations...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jean-Baptiste Micol, Alessandro Pastore, Daichi Inoue, Nicolas Duployez, Eunhee Kim, Stanley Chun-Wei Lee, Benjamin H. Durham, Young Rock Chung, Hana Cho, Xiao Jing Zhang, Akihide Yoshimi, Andrei Krivtsov, Richard Koche, Eric Solary, Amit Sinha, Claude Preudhomme, Omar Abdel-Wahab
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Q
Acceso en línea:https://doaj.org/article/4858a0bedd1541a2a819f03ad5087413
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4858a0bedd1541a2a819f03ad5087413
record_format dspace
spelling oai:doaj.org-article:4858a0bedd1541a2a819f03ad50874132021-12-02T15:38:39ZASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia10.1038/ncomms154292041-1723https://doaj.org/article/4858a0bedd1541a2a819f03ad50874132017-05-01T00:00:00Zhttps://doi.org/10.1038/ncomms15429https://doaj.org/toc/2041-1723While the role of ASLX1 in haematopoiesis and leukaemia has been heavily studied, the role of ASLX2 is unclear. Here the authors show that ASLX2 is required for normal haematopoietic stem cell self-renewal whereas Asxl2 loss promotes leukemogenesis, thus explaining the frequently observed mutations in AML patientsJean-Baptiste MicolAlessandro PastoreDaichi InoueNicolas DuployezEunhee KimStanley Chun-Wei LeeBenjamin H. DurhamYoung Rock ChungHana ChoXiao Jing ZhangAkihide YoshimiAndrei KrivtsovRichard KocheEric SolaryAmit SinhaClaude PreudhommeOmar Abdel-WahabNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-13 (2017)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Jean-Baptiste Micol
Alessandro Pastore
Daichi Inoue
Nicolas Duployez
Eunhee Kim
Stanley Chun-Wei Lee
Benjamin H. Durham
Young Rock Chung
Hana Cho
Xiao Jing Zhang
Akihide Yoshimi
Andrei Krivtsov
Richard Koche
Eric Solary
Amit Sinha
Claude Preudhomme
Omar Abdel-Wahab
ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia
description While the role of ASLX1 in haematopoiesis and leukaemia has been heavily studied, the role of ASLX2 is unclear. Here the authors show that ASLX2 is required for normal haematopoietic stem cell self-renewal whereas Asxl2 loss promotes leukemogenesis, thus explaining the frequently observed mutations in AML patients
format article
author Jean-Baptiste Micol
Alessandro Pastore
Daichi Inoue
Nicolas Duployez
Eunhee Kim
Stanley Chun-Wei Lee
Benjamin H. Durham
Young Rock Chung
Hana Cho
Xiao Jing Zhang
Akihide Yoshimi
Andrei Krivtsov
Richard Koche
Eric Solary
Amit Sinha
Claude Preudhomme
Omar Abdel-Wahab
author_facet Jean-Baptiste Micol
Alessandro Pastore
Daichi Inoue
Nicolas Duployez
Eunhee Kim
Stanley Chun-Wei Lee
Benjamin H. Durham
Young Rock Chung
Hana Cho
Xiao Jing Zhang
Akihide Yoshimi
Andrei Krivtsov
Richard Koche
Eric Solary
Amit Sinha
Claude Preudhomme
Omar Abdel-Wahab
author_sort Jean-Baptiste Micol
title ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia
title_short ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia
title_full ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia
title_fullStr ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia
title_full_unstemmed ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia
title_sort asxl2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/4858a0bedd1541a2a819f03ad5087413
work_keys_str_mv AT jeanbaptistemicol asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT alessandropastore asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT daichiinoue asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT nicolasduployez asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT eunheekim asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT stanleychunweilee asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT benjaminhdurham asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT youngrockchung asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT hanacho asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT xiaojingzhang asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT akihideyoshimi asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT andreikrivtsov asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT richardkoche asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT ericsolary asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT amitsinha asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT claudepreudhomme asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
AT omarabdelwahab asxl2isessentialforhaematopoiesisandactsasahaploinsufficienttumoursuppressorinleukemia
_version_ 1718386106981941248